Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract invites limited competition applications for a three-year extension of the COPE-AKI clinical trial consortium, which currently comprises three clinical centers and one scientific and data research center. The goal is to fully meet enrollment targets, complete participant follow-up, and support data analysis and dissemination of study results. This continuation is critical as there is currently no established standard of care for patients following hospitalization with acute kidney injury (AKI). The successful completion of this study aims to generate essential insights that can guide improved clinical management and the development of standard care protocols for survivors of Stage 2 and 3 AKI. This forecasted Notice of Funding Opportunity (NOFO) is issued by the National Institutes of Health, part of the Department of Health and Human Services, and will solicit applications from eligible organizations. Submitted applications will undergo peer review and funding will be awarded based on merit. The contract point of contact is Ivonne Schulman, who can be reached via email or phone for additional information. The initiative highlights the importance of continuing this clinical research to enhance patient outcomes and establish evidence-based care practices in treating AKI survivors.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
This NOFO requests limited competition applications for a 3-year extension of the COPE-AKI clinical trial consortium, which includes three clinical centers (CCs) and one scientific and data research center (SDRC), are requested to fully meet the enrollment targets, complete participant follow-up, and provide resources for data analysis and dissemination of study findings. There is currently no standard of care for patients after hospitalization with acute kidney injury (AKI). Successful completion of the COPE-AKI study will provide key insights that are expected to directly inform improved clinical management strategies and the development of standard of care for Stage 2 and 3 AKI survivors.
This is a forecast for a limited competition Notice of Funding Opportunity (NOFO) that will invite application(s) from eligible organizations to apply. Application(s) will be peer-reviewed and only funded if meritorious.
